These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New insights into the pathogenesis of asthma. Simon HU Curr Probl Dermatol; 1999; 28():124-8. PubMed ID: 10374059 [No Abstract] [Full Text] [Related]
3. Mutations in apoptosis genes: a pathogenetic factor for human disease. Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650 [TBL] [Abstract][Full Text] [Related]
4. Selective protection by hsp 70 against cytotoxic drug-, but not Fas-induced T-cell apoptosis. Creagh EM; Cotter TG Immunology; 1999 May; 97(1):36-44. PubMed ID: 10447712 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells. Simizu S; Shibasaki F; Osada H Jpn J Cancer Res; 2000 Jul; 91(7):706-14. PubMed ID: 10920278 [TBL] [Abstract][Full Text] [Related]
6. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637 [TBL] [Abstract][Full Text] [Related]
8. Targeting apoptosis in prostate cancer. DiPaola RS; Patel J; Rafi MM Hematol Oncol Clin North Am; 2001 Jun; 15(3):509-24. PubMed ID: 11525294 [TBL] [Abstract][Full Text] [Related]
10. Small stress proteins: novel negative modulators of apoptosis induced independently of reactive oxygen species. Arrigo AP; Paul C; Ducasse C; Manero F; Kretz-Remy C; Virot S; Javouhey E; Mounier N; Diaz-Latoud C Prog Mol Subcell Biol; 2002; 28():185-204. PubMed ID: 11908059 [No Abstract] [Full Text] [Related]
11. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas). Umansky V; Ushmorov A; Ratter F; Chlichlia K; Bucur M; Lichtenauer A; Rocha M Int J Oncol; 2000 Jan; 16(1):109-17. PubMed ID: 10601555 [TBL] [Abstract][Full Text] [Related]
12. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma. Alas S; Ng CP; Bonavida B Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917 [TBL] [Abstract][Full Text] [Related]
13. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels. Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839 [TBL] [Abstract][Full Text] [Related]
14. The role of Bcl-2 family proteins in chronic lymphocytic leukaemia. Buggins AG; Pepper CJ Leuk Res; 2010 Jul; 34(7):837-42. PubMed ID: 20359747 [TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of apoptosis. Fas and TNF systems. ICE protease system. Bcl-2 family]. Goga LM; Vasiliu OM; Ionescu CR Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):23-9. PubMed ID: 12092154 [TBL] [Abstract][Full Text] [Related]
17. Ajoene, an experimental anti-leukemic drug: mechanism of cell death. Dirsch VM; Antlsperger DS; Hentze H; Vollmar AM Leukemia; 2002 Jan; 16(1):74-83. PubMed ID: 11840266 [TBL] [Abstract][Full Text] [Related]
18. Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. Hua F; Cornejo MG; Cardone MH; Stokes CL; Lauffenburger DA J Immunol; 2005 Jul; 175(2):985-95. PubMed ID: 16002698 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727 [TBL] [Abstract][Full Text] [Related]
20. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis. Greenland C; Touriol C; Chevillard G; Morris SW; Bai R; Duyster J; Delsol G; Allouche M Oncogene; 2001 Nov; 20(50):7386-97. PubMed ID: 11704868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]